Expiration date: 04/2026

Structure and Composition: 

Suspension for injection. 1 ml contains 150 mg of medroxyprogesterone acetate

Excipients: polyethylene glycol 3350, polysorbate 80 methylparaben propylparaben sodium chloride, water for injection

in Disposable syringes and vials of 1 ml or in vials of 3.3 and 6.7 ml in the paper cartons 1 syringe or vial 1.

Description pharmaceutical form:

Sterile suspension of white color.

Dosage and administration:

V / m. Endometrial cancer and kidney cancer: 400-1000 mg per week for several weeks or months after the stabilization supporting therapy - 400 mg per month.

Breast Cancer: 500 mg / day for 28 days, then move on to a maintenance dose - 500 mg 2 times a week until evidence of disease progression.

Immediately before use, the vial should be shaken well to the medication injected acquired form of uniform slurry.